Not available
Quote | Aurinia Pharmaceuticals Inc (NASDAQ:AUPH)
Last: | $5.61 |
---|---|
Change Percent: | -0.18% |
Open: | $5.48 |
Close: | $5.61 |
High: | $5.61 |
Low: | $5.44 |
Volume: | 813,314 |
Last Trade Date Time: | 07/05/2024 03:00:00 am |
News | Aurinia Pharmaceuticals Inc (NASDAQ:AUPH)
2024-07-05 14:10:21 ET Summary Aurinia Pharmaceuticals stock has dropped more than 80% due to disappointing Lupkynis sales since its launch in 2021. Management is focusing solely on driving Lupkynis sales and cutting costs by laying off 25% of its sales force and discontinuing oth...
2024-06-27 04:10:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Message Board Posts | Aurinia Pharmaceuticals Inc (NASDAQ:AUPH)
Subject | By | Source | When |
---|---|---|---|
Ha! | Ganz | investorshub | 04/30/2023 4:23:08 PM |
I did the same and I have a | kipster210 | investorshub | 04/29/2023 9:45:03 PM |
Just voted NO on everything management wants and | Benny450 | investorshub | 04/29/2023 8:49:52 PM |
They probably tallying up the votes and it | Cosa | investorshub | 04/28/2023 10:21:53 PM |
I would never touch that shitplaying right into | greggors | investorshub | 04/28/2023 9:55:27 PM |
News, Short Squeeze, Breakout and More Instantly...
Aurinia Pharmaceuticals Inc Company Name:
AUPH Stock Symbol:
NASDAQ Market:
Aurinia Pharmaceuticals Inc Website:
2024-06-27 04:10:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (Aurinia or the Company) today announced voting results for its 2024 annual general meeting (the Meeting) of shareholders held on June 14, 2024. Shareholders re-elected five of nine incumbent directors to the Board of Directors (the Board). The four...
Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (Aurinia or the Company), today announced an oral presentation at the European Alliance of Associations for Rheumatology (EULAR) 2024 taking place in Vienna, Austria June 12-15. The data reinforces previous findings from the AURORA Clinical Program ...